About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clinical Trial of Factor XIII (FXIII) Concentrate

NCT00640289·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Children's Hospital of Orange County

With

CSL Behring

Age

Any age

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Patients may be of either sex or age. Children and newborn infants are specifically included in this study.
Patient must have documented congenital Factor XIII deficiency
Patient or legal guardian must sign informed consent
Patients who have negative serology for hepatitis B should receive Hepatitis B vaccination.

You may not be if

Patient has acquired Factor XIII deficiency

The record

StatusCompleted

PhaseNo phase

Taking part72

StartedJan 2000

UpdatedNov 7, 2018

Conditions

Hemophilia Factor XIII Deficiency

Where1

Children's Hospital of Orange Co.
Orange, California, United States

Clareo Health | Clinical Trial of Factor XIII (FXIII) Concentrate